TITLE

Arrhythmias in chronic kidney disease

AUTHOR(S)
Roberts, Paul R.; Green, Darren
PUB. DATE
May 2011
SOURCE
Heart;May2011, Vol. 97 Issue 9, p14
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the medical management of arrhythmias in patients with chronic kidney disease (CKD). It describes CKD, identifying its causes, most common of which are hypertension and diabetes mellitus, and the greatest cause of death which is premature cardiovascular disease. It notes the interdependence of cardiac and renal systems in treating arrhythmias in CKD patients. It stresses that medical management should focus on risk reduction for sudden cardiac death (SCD) to include drug treatments and changes in lifestyle and dialysis prescription.
ACCESSION #
60605603

 

Related Articles

  • The Quiet Killer. O. Z., Mehmet // O, The Oprah Magazine;Oct2010, Vol. 11 Issue 10, p154 

    In this article, the author reports on chronic kidney disease (CKD), a life-threatening disease that afflicts millions of people in the U.S. CKD occurs when over the course of several months to years, the organs' tiny filters are progressively damaged. Diabetes and hypertension, together account...

  • C. Hypertension and Systemic Disease.  // Kidney;Nov/Dec2003, Vol. 12 Issue 6, p271 

    Presents abstract of medical case studies on hypertension and systemic disease. "Renal Insufficiency in the Absence of Albuminuria and Retinopathy Among Adults with Type 2 Diabetes Mellitus"; "Prevalence of Renal Artery Stenosis in High-Risk Veterans Referred to Cardiac Catheterization";...

  • Management of chronic kidney disease in primary health care: position paper of the European Forum for Primary Care. Rosenberg, Mai; Kalda, Ruth; Kasiulevičius, Vytautas; Lember, Margus // Quality in Primary Care;2008, Vol. 16 Issue 4, p279 

    The article presents a study on the management of different chronic kidney disease (CKD) stages with recommendations and shared care interventions. CKD has been classified as a "silent" disease and a worldwide problem to public health. It cites the causes of the disease inlcuding diabetes and...

  • COPING WITH CHRONIC KIDNEY DISEASE. Magill-Lewis, Jillene // Drug Topics;9/27/2004, Vol. 148 Issue 18, pHSE21 

    This article states that the rise in obesity in the United States has led to an increased incidence of diabetes, the leading cause of chronic kidney disease (CKD). The two primary results of CKD are loss of kidney function and the development of cardiovascular disease. The National Kidney...

  • An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting. Palmer, A.J.; Annemans, L.; Roze, S.; Lamotte, M.; Rodby, RA; Bilous, RW // Journal of Human Hypertension;Oct2004, Vol. 18 Issue 10, p733 

    There are substantial healthcare costs associated with the provision of renal replacement therapy. Patients with diabetes mellitus are the largest and fastest growing group developing end-stage renal disease (ESRD) in the United Kingdom (UK). Treatment leading to a slowing of progression to ESRD...

  • Introduction: Adequacy of dialysis in treatment and prevention of cardiovascular complications. Merrill, John P. // Kidney International Supplement;Jan1975, Issue 2, pS-154 

    This article presents information on adequacy of dialysis in treatment and prevention of cardiovascular complications. Disease of the cardiovascular system is the major cause of death in patients on chronic hemodialysis. It appears to be accelerated either by the process of chronic renal failure...

  • FIRST COMMUNITY-BASED SCREENING FOR CHRONIC KIDNEY DISEASE, HYPERTENSION AND DIABETES IN DHARAN, NEPAL. K., Sharma S.; P., Karki; R., Shrestha N.; L., Thapa; S., Chaudhary; R., Tamrakar; S., Dhakal; R., Deo; N., Baral; R., Maskey; M., Parajuli; S., Kumar // Indian Journal of Nephrology;Jul-Sep2007, Vol. 17 Issue 3, p113 

    Aims: Nepal cannot afford renal replacement therapy (RRT) for ESRD due to lack of resources. Early diagnosis of CKD and its risk factors may reduce the need of RRT. Materials and Methods: In this first community-based screening program in Nepal, 3218 people iÝ 20 years were assessed by...

  • Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Ayinuer Adijiang; Sumie Goto; Satsuki Uramoto; Fuyuhiko Nishijima; Toshimitsu Niwa // Nephrology Dialysis Transplantation;Jun2008, Vol. 23 Issue 6, p1892 

    Background. Stage 5 chronic kidney disease (CKD) is associated with enhanced aortic calcification. The aim of this study was to determine if the administration of indoxyl sulphate (IS), a uraemic toxin, stimulates the progression of aortic calcification. Methods. The rat groups consisted of (i)...

  • The increasing prevalence of diabetic nephropathy as a cause of end stage renal disease in Nigeria. Alebiosu, C. O.; Ayodele, O. E. // Tropical Doctor;Oct2006, Vol. 36 Issue 4, p218 

    The incidence of diabetic nephropathy, the leading cause of chronic kidney disease in the western world has increased by 150% in the past 10 years in the United States, with similar trends in Europe and Japan. It is apparent from the present study that diabetic nephropathy may be assuming an...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics